Skip to Content

Pasireotide

In the US, Pasireotide (pasireotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly and Cushing's Syndrome.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H01CB05

CAS registry number (Chemical Abstracts Service)

0396091-73-9

Chemical Formula

C58-H66-N10-O9

Molecular Weight

1047

Therapeutic Categories

Growth hormone release inhibiting hormone, GHRIH (somatostatin)

Analogue of growth hormone (somatropin)

Chemical Name

Cyclo[(4R)-4-(2-aminoetylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L-phenylalanyl-) (WHO)

Foreign Names

  • Pasireotidum (Latin)
  • Pasireotid (German)
  • PasirĂ©otide (French)
  • Pasireotida (Spanish)

Generic Names

  • Pasireotide (OS: USAN, BAN)
  • SOM 230 (IS)
  • UNII-98H1T17066 (IS)
  • Pasireotid aspartat (IS)
  • Pasireotid L-aspartat (IS)
  • Pasireotide aspartate (IS)
  • Pasireotide L-aspartate (IS)
  • SOM-230B (IS)
  • Pasireotid embonat (IS)
  • Pasireotid embonate (IS)
  • UNII-04F55A7UZ3 (IS)

Brand Names

  • Signifor
    Novartis, Bosnia & Herzegowina; Novartis, Denmark; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Israel; Novartis, Poland; Novartis, Romania; Novartis, Slovakia; Novartis, Thailand; Novartis Europharm, Greece; Novartis Europharm, Slovenia; Novartis Farma, Italy; Novartis Pharmaceuticals, Canada; Novartis, Iceland; Novartis, Lithuania; Novartis, Finland; Novartis, France; Novartis, Norway; Novartis, Sweden; Novartis, United States; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals UK, United Kingdom; Novartis Europharm, Austria; Novartis, France; Novartis Pharma, Germany
  • Signifor LAR
    Novartis, United States; Novartis Pharma, Switzerland

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide